Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

189.27
Delayed Data
As of 4:02pm ET
 +2.12 / +1.13%
Today’s Change
182.80
Today|||52-Week Range
256.80
-9.88%
Year-to-Date
SeaBridge Investment Advisors LLC Buys Seagate Technology PLC, , Steelcase Inc, Sells...
2:38pm / GuruFocus News - Paid Partner Content
Harvey Investment Co Llc Buys Hexcel Corp, DowDuPont Inc, Duke Energy Corp, Sells All...
Oct 18 / GuruFocus News - Paid Partner Content
Allergan's Hard Fall Is Not Enough of a Reason to Buy
11:27am / TheStreet.com - Paid Partner Content
Allergan Shares Are Ready for a 30% Bounce Within Days
Oct 18 / TheStreet.com - Paid Partner Content
Company News For Oct 19, 2017
10:42am / Zacks.com - Paid Partner Content
Recommended Allergan Reading
Oct 18 / TheStreet.com - Paid Partner Content
Conatus Entrusts Keith W. Marshall With Key Management Roles
10:13am / Zacks.com - Paid Partner Content
Cramer: Getting Out the Bad News Gives a Post-Earnings Boost
Oct 17 / TheStreet.com - Paid Partner Content
Allergan Still Slipping; I'm Not Buying (Yet)
9:40am / TheStreet.com - Paid Partner Content
Aerie (AERI) Up on FDA Review Committee Result for Rhopressa
Oct 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close187.15
Today’s open185.22
Day’s range182.80 - 190.69
Volume7,560,353
Average volume (3 months)2,455,057
Market cap$62.6B
Dividend yield1.48%
Data as of 4:02pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.94%
Earnings growth (next 5 years)+11.83%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.06+0.17%
LLYEli Lilly and Co+0.63+0.73%
ABTAbbott Laboratories+0.23+0.41%
NVONovo Nordisk+0.55+1.10%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.06
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts